Alpha Tau Medical Ltd. held its Annual General Meeting of Shareholders on June 17, 2025, at its headquarters in Jerusalem, Israel. Shareholders approved the re-election of Alan Adler and S. Morry Blumenfeld, and the election of Nadav Kidron as Class I directors. The issuance of warrants to purchase a total of 3,237,000 ordinary shares was also approved, along with the re-appointment of Kost, Forer, Gabbay & Kasierer as the independent registered public accounting firm for 2025. An amendment to the Non-Employee Director Compensation Package was ratified as well. All proposals received the necessary approvals.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.